Search Results 801-810 of 18202 for Immunode

1. A Study to Evaluate the Long-Term Safety of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD) - Mayo Clinic

   About this study. The purpose of this study is to assess the long-term tolerability and safety of oral nintedanib treatment in patients with Progressive ...

2. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

   Subjects with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C. Subjects with any other medical or psychological condition ...

3. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

   Positive serology and/or nucleic acid testing (NAT) for human immunodeficiency virus (HIV). Serology and/or NAT indicating active hepatitis B virus (HBV) ...

4. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

   Known seropositivity for or active infection by human immunodeficiency virus (HIV);; Active Hepatitis B (by surface antigen expression or polymerase chain ...

5. A Study Evaluating the Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

   Known history of infection with human immunodeficiency virus (HIV) or hepatitis B (HBsAg positive) or hepatitis C virus (anti-HCV positive). If there is a ...

6. Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   Has known human immunodeficiency virus (HIV) and CD4 count < 350 cells/μL and/or a history of an AIDS-defining opportunistic infection within the past 12 months ...

7. Myocardial Ischemia and Transfusion - Mayo Clinic

   Inclusion Criteria: 18 years of age or older; Either ST segment elevation myocardial infarction or Non ST segment elevation myocardial infarction consistent ...

8. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

   Patients who are known to be human immunodeficiency virus (HIV)-positive are eligible providing they meet all of the following additional criteria within 28 ...

9. A Study to Evaluate Placental Pathologies Using Ultrasound of the Human Placenta - Mayo Clinic

   Known immunodeficiency. Chronic, active viral infections, including HIV-1/2, HTLV-1/2, hepatitis B/C. Known autoimmune disease (e.g., rheumatoid arthritis ...

10. Examining the efficacy of recombinant zoster vaccination in patients with IBD - Mayo Clinic

    ... immunodeficiency virus (HIV), chronic kidney disease, other autoimmune diseases and patients after transplantation. The patients were followed for a mean of ...